David Reynolds Email

CEO . LoQus23 Therapeutics Ltd

Cambridge, Cambridgeshire

Location

LinkedIn

Current Roles

Employees:
18
Revenue:
$1.4M
About
LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases.
LoQus23 Therapeutics Ltd Address
Building 522, Babraham Research Campus
Cambridge, Cambridgeshire
LoQus23 Therapeutics Ltd Email